India · Delayed Price · Currency is INR Sanofi India Statistics
Total Valuation
Sanofi India has a market cap or net worth of INR 73.65 billion. The enterprise value is 70.11 billion.
| Market Cap | 73.65B |
| Enterprise Value | 70.11B |
Important Dates
The last earnings date was Tuesday, August 4, 2026.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | Apr 22, 2026 |
Share Statistics
Sanofi India has 23.03 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Current Share Class | 23.03M |
| Shares Outstanding | 23.03M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 24.54% |
| Float | 9.07M |
Valuation Ratios
The trailing PE ratio is 22.75 and the forward PE ratio is 18.21.
| PE Ratio | 22.75 |
| Forward PE | 18.21 |
| PS Ratio | 4.08 |
| PB Ratio | 8.92 |
| P/TBV Ratio | 8.92 |
| P/FCF Ratio | 21.89 |
| P/OCF Ratio | 20.53 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.52, with an EV/FCF ratio of 20.84.
| EV / Earnings | 21.65 |
| EV / Sales | 3.88 |
| EV / EBITDA | 14.52 |
| EV / EBIT | 15.71 |
| EV / FCF | 20.84 |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.69 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | 0.04 |
| Interest Coverage | 279.00 |
Financial Efficiency
Return on equity (ROE) is 40.27% and return on invested capital (ROIC) is 68.01%.
| Return on Equity (ROE) | 40.27% |
| Return on Assets (ROA) | 21.09% |
| Return on Invested Capital (ROIC) | 68.01% |
| Return on Capital Employed (ROCE) | 53.31% |
| Weighted Average Cost of Capital (WACC) | 5.36% |
| Revenue Per Employee | 16.46M |
| Profits Per Employee | 2.95M |
| Employee Count | 1,097 |
| Asset Turnover | 1.36 |
| Inventory Turnover | 3.16 |
Taxes
In the past 12 months, Sanofi India has paid 1.12 billion in taxes.
| Income Tax | 1.12B |
| Effective Tax Rate | 25.65% |
Stock Price Statistics
The stock price has decreased by -37.17% in the last 52 weeks. The beta is 0.20, so Sanofi India's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | -37.17% |
| 50-Day Moving Average | 3,342.25 |
| 200-Day Moving Average | 3,751.54 |
| Relative Strength Index (RSI) | 33.47 |
| Average Volume (20 Days) | 1,492 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi India had revenue of INR 18.05 billion and earned 3.24 billion in profits. Earnings per share was 140.59.
| Revenue | 18.05B |
| Gross Profit | 8.85B |
| Operating Income | 4.46B |
| Pretax Income | 4.36B |
| Net Income | 3.24B |
| EBITDA | 4.78B |
| EBIT | 4.46B |
| Earnings Per Share (EPS) | 140.59 |
Balance Sheet
The company has 3.69 billion in cash and 147.00 million in debt, with a net cash position of 3.54 billion or 153.71 per share.
| Cash & Cash Equivalents | 3.69B |
| Total Debt | 147.00M |
| Net Cash | 3.54B |
| Net Cash Per Share | 153.71 |
| Equity (Book Value) | 8.26B |
| Book Value Per Share | 358.69 |
| Working Capital | 3.95B |
Cash Flow
In the last 12 months, operating cash flow was 3.59 billion and capital expenditures -223.00 million, giving a free cash flow of 3.36 billion.
| Operating Cash Flow | 3.59B |
| Capital Expenditures | -223.00M |
| Depreciation & Amortization | 311.00M |
| Net Borrowing | -38.00M |
| Free Cash Flow | 3.36B |
| FCF Per Share | 146.07 |
Margins
Gross margin is 49.01%, with operating and profit margins of 24.73% and 17.94%.
| Gross Margin | 49.01% |
| Operating Margin | 24.73% |
| Pretax Margin | 24.12% |
| Profit Margin | 17.94% |
| EBITDA Margin | 26.45% |
| EBIT Margin | 24.73% |
| FCF Margin | 18.64% |
Dividends & Yields
This stock pays an annual dividend of 123.00, which amounts to a dividend yield of 3.79%.
| Dividend Per Share | 123.00 |
| Dividend Yield | 3.79% |
| Dividend Growth (YoY) | 5.13% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 87.46% |
| Buyback Yield | -0.00% |
| Shareholder Yield | 3.79% |
| Earnings Yield | 4.40% |
| FCF Yield | 4.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Sanofi India is 4,339.67, which is 35.70% higher than the current price. The consensus rating is "Buy".
| Price Target | 4,339.67 |
| Price Target Difference | 35.70% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | 6.10% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |